Novavax COVID shot, aimed at vaccine skeptics, overwhelmingly backed by FDA panel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 11.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.32 | 52 Week High | $9.23 | |||
| Open | $11.32 | 52 Week Low | $1.16 | |||
| Day High | $11.32 | P/E | N/A | |||
| Day Low | $11.32 | EPS | $-0.30 | |||
| Volume | 51,410 | |||||
